Related Experiment Video
Updated: Feb 4, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Solasodine reverses stemness and epithelial-mesenchymal transition in human colorectal cancer
Yu-Wen Zhuang1, Cun-En Wu2, Jin-Yong Zhou2
1The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of TCM, Nanjing, China; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China; Department of Integrated Traditional and Western Medicine, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Abstract:
Adverse side effects of conventional chemotherapy, acquired resistance and fatal tumor metastasis of human colorectal cancer (CRC) are propelling the exploration for novel selective anticarcinogens. Solasodine is a main active component isolated from Solanum incanum L that exhibited a potent stemness and invasion inhibitory effect on human colorectal cancer HCT116 cells. Colony Spheroid formation assay showed that solasodine dose-dependently prohibited HCT116 cell stemness. CD133, CD44, Nanog, Oct-4 and Sox-2 were inhibited by solasodine to reverse stemness and similar mechanism was stimulated in vivo. Transwell and scratch wound assays revealed that solasodine impeded HCT116 cell invasion and migration potential strengthened by TGF-β1. Moreover, solasodine attenuated TGF-β1-induced EMT and decreased MMPs while in vivo study showed the same trend. The results of this study implied that solasodine may be a novel therapeutic drug for CRC treatment.
Insights
Solasodine, derived from Solanum incanum L, effectively inhibits colorectal cancer (CRC) stemness and invasion. This natural compound shows promise as a novel therapeutic agent for CRC treatment.
Area of Science:
- Oncology
- Natural Product Chemistry
- Molecular Biology
Background:
- Conventional chemotherapy for colorectal cancer (CRC) presents challenges including side effects, resistance, and metastasis.
- There is a critical need for novel, selective anticarcinogenic agents to overcome these limitations.
Purpose of the Study:
- To investigate the potential of solasodine, a component of Solanum incanum L, as a therapeutic agent against human colorectal cancer.
- To evaluate solasodine's effects on cancer stemness, invasion, and migration in HCT116 cells and in vivo.
Main Methods:
- Colony spheroid formation assays were used to assess cancer stemness.
- Transwell and scratch wound assays evaluated cell invasion and migration.
- Expression of stemness markers (CD133, CD44, Nanog, Oct-4, Sox-2) and epithelial-mesenchymal transition (EMT) markers were analyzed.
- In vivo studies were conducted to validate the observed effects.
Main Results:
- Solasodine dose-dependently inhibited HCT116 cell stemness by downregulating key stemness markers.
- Solasodine significantly impeded HCT116 cell invasion and migration, particularly in the presence of TGF-β1.
- The compound attenuated TGF-β1-induced EMT and reduced matrix metalloproteinases (MMPs) expression, consistent in both in vitro and in vivo models.
Conclusions:
- Solasodine demonstrates potent inhibitory effects on colorectal cancer stemness and invasion.
- Solasodine may serve as a promising novel therapeutic candidate for colorectal cancer treatment.
Related Concept Videos
Mesenchymal Stem Cells
Phase Transitions
Phase Transitions: Vaporization and Condensation
Phase Transitions: Sublimation and Deposition
Phase Transitions: Melting and Freezing
Properties of Transition Metals

